Leap Therapeutics, Inc. (LPTX): Price and Financial Metrics

LPTX POWR Grades

• Value is the dimension where LPTX ranks best; there it ranks ahead of 39.42% of US stocks.
• The strongest trend for LPTX is in Value, which has been heading down over the past 169 days.
• LPTX's current lowest rank is in the Momentum metric (where it is better than 4.01% of US stocks).

LPTX Stock Summary

• For LPTX, its debt to operating expenses ratio is greater than that reported by just 0.39% of US equities we're observing.
• LPTX's price/sales ratio is 103.63; that's higher than the P/S ratio of 97.63% of US stocks.
• With a year-over-year growth in debt of -100%, Leap Therapeutics Inc's debt growth rate surpasses only 0% of about US stocks.
• Stocks that are quantitatively similar to LPTX, based on their financial statements, market capitalization, and price volatility, are MGNX, PLRX, SQZ, ABUS, and JNCE.
• LPTX's SEC filings can be seen here. And to visit Leap Therapeutics Inc's official web site, go to www.leaptx.com.

LPTX Valuation Summary

• In comparison to the median Healthcare stock, LPTX's price/sales ratio is 1700% higher, now standing at 68.4.
• LPTX's EV/EBIT ratio has moved up 0.5 over the prior 56 months.
• LPTX's price/earnings ratio has moved up 0.3 over the prior 56 months.

Below are key valuation metrics over time for LPTX.

LPTX Growth Metrics

Its 2 year net income to common stockholders growth rate is now at -34.48%.
• Its 4 year net cashflow from operations growth rate is now at 5.43%.
• Its 4 year net income to common stockholders growth rate is now at -62.3%.

Over the past 27 months, LPTX's revenue has gone up $1,500,000.

The table below shows LPTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	1.5	-30.429	-36.509
2021-06-30	1.5	-28.919	-32.427
2021-03-31	1.5	-30.618	-29.417
2020-12-31	1.5	-25.957	-37.588
2020-09-30	1.125	-25.863	-38.874
2020-06-30	0.75	-26.228	-39.752

LPTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LPTX has a Quality Grade of D, ranking ahead of 18.21% of graded US stocks.
• LPTX's asset turnover comes in at 0.03 -- ranking 351st of 682 Pharmaceutical Products stocks.
• LNTH, ADMP, and CASI are the stocks whose asset turnover ratios are most correlated with LPTX.

The table below shows LPTX's key quality metrics over time.